|
|
|
Targets from reference |
Targets from TarBase |
|
|
Detail |
| hsa-miR-15a |
|
Causal |
BCL2, RAS |
unknown |
MicroRNA gene expression during retinoic acid-induced differentiation of human acute promyelocytic leukemia. |
2007 |
|
|
|
|
|
|
| hsa-let-7d |
|
Causal |
BCL2, RAS |
unknown |
MicroRNA gene expression during retinoic acid-induced differentiation of human acute promyelocytic leukemia. |
2007 |
|
|
|
|
|
|
| hsa-let-7a-3 |
|
Causal |
BCL2, RAS |
unknown |
MicroRNA gene expression during retinoic acid-induced differentiation of human acute promyelocytic leukemia. |
2007 |
|
|
|
|
|
|
| hsa-let-7c |
|
Causal |
BCL2, RAS |
unknown |
MicroRNA gene expression during retinoic acid-induced differentiation of human acute promyelocytic leukemia. |
2007 |
|
|
|
|
|
|
| hsa-miR-16-1 |
|
Causal |
BCL2, RAS |
unknown |
MicroRNA gene expression during retinoic acid-induced differentiation of human acute promyelocytic leukemia. |
2007 |
|
|
|
|
|
|
| hsa-miR-21 |
|
Causal |
PTEN, BCL2 |
PTEN,TPM1 |
MicroRNA expression signature and antisense-mediated depletion reveal an essential role of MicroRNA in vascular neointimal lesion formation. |
2007 |
|
|
|
|
|
|
| hsa-miR-15a |
|
Causal |
BCL2 |
unknown |
miR-15 and miR-16 induce apoptosis by targeting BCL2. |
2005 |
|
|
|
|
|
|
| hsa-miR-16-1 |
|
Causal |
BCL2 |
unknown |
miR-15 and miR-16 induce apoptosis by targeting BCL2. |
2005 |
|
|
|
|
|
|
| hsa-miR-15a |
|
Causal |
BCL2 |
unknown |
The role of microRNA and other non-coding RNA in the pathogenesis of chronic lymphocytic leukemia. |
2007 |
|
|
|
|
|
|
| hsa-miR-16-1 |
|
Causal |
BCL2 |
unknown |
The role of microRNA and other non-coding RNA in the pathogenesis of chronic lymphocytic leukemia. |
2007 |
|
|
|
|
|
|
| hsa-miR-16 |
|
Causal |
BCL2 |
BCL2,CGI-38 |
Abnormal microRNA-16 locus with synteny to human 13q14 linked to CLL in NZB mice. |
2007 |
|
|
|
|
|
|
| hsa-miR-21 |
|
Causal |
BCL2 |
PTEN,TPM1 |
miR-21-mediated tumor growth. |
2007 |
|
|
|
|
|
|
| hsa-miR-34a |
|
Causal |
BCL2 |
E2F3 |
p53-mediated activation of miRNA34 candidate tumor-suppressor genes. |
2007 |
|
|
|
|
|
|
| hsa-miR-34b |
|
Causal |
BCL2 |
unknown |
p53-mediated activation of miRNA34 candidate tumor-suppressor genes. |
2007 |
|
|
|
|
|
|
| hsa-miR-34c |
|
Causal |
BCL2 |
unknown |
p53-mediated activation of miRNA34 candidate tumor-suppressor genes. |
2007 |
|
|
|
|
|
|
| hsa-miR-34a |
|
Causal |
BIRC3,DcR3,BCL2 |
E2F3 |
Transactivation of miR-34a by p53 broadly influences gene expression and promotes apoptosis. |
2007 |
|
|
|
|
|
|
| hsa-miR-15b |
|
Causal |
BCL2 |
unknown |
miR-15b and miR-16 modulate multidrug resistance by targeting BCL2 in human gastric cancer cells. |
2008 |
|
|
|
|
|
|
| hsa-miR-16 |
|
Causal |
BCL2 |
BCL2,CGI-38 |
miR-15b and miR-16 modulate multidrug resistance by targeting BCL2 in human gastric cancer cells. |
2008 |
|
|
|
|
|
|
| hsa-miR-133b |
|
Causal |
Mcl-1, BCL2L2 |
unknown |
MicroRNA 133B targets pro-survival molecules MCL-1 and BCL2L2 in lung cancer. |
2009 |
|
|
|
|
|
|
| hsa-miR-153 |
|
Causal |
Mcl-1, BCL2 |
unknown |
Down-regulations of B-cell lymphoma 2 (Bcl-2) and myeloid cell leukemia sequence 1 (Mcl-1) by MicroRNA 153 induce apoptosis in a glioblastoma cell line DBTRG-05MG. |
2009 |
|
|
|
|
|
|
| hsa-miR-34a |
|
Causal |
BCL2 |
E2F3 |
miR-34a, a microRNA up-regulated in a double transgenic mouse model of Alzheimer's disease, inhibits bcl2 translation. |
2009 |
|
|
|
|
|
|
| hsa-miR-34a |
|
Causal |
BCL2, MYCN |
E2F3 |
A functional screen identifies miR-34a as a candidate neuroblastoma tumor suppressor gene. |
2008 |
|
|
|
|
|
|
| hsa-miR-16a |
|
Causal |
BCL2 |
unknown |
Down-regulation of the microRNAs miR-34a, miR-127, and miR-200b in rat liver during hepatocarcinogenesis induced by a methyl-deficient diet. |
2008 |
|
|
|
|
|
|
| hsa-miR-204 |
|
Causal |
Mcl-1, BCL2 |
unknown |
The role of microRNA expression pattern in human intrahepatic cholangiocarcinoma. |
2009 |
|
|
|
|
|
|
| hsa-miR-320 |
|
Causal |
Mcl-1, BCL2 |
unknown |
The role of microRNA expression pattern in human intrahepatic cholangiocarcinoma. |
2009 |
|
|
|
|
|
|
| hsa-miR-16 |
|
Causal |
BCL2 |
BCL2,CGI-38 |
Epigallocatechin gallate up-regulation of miR-16 and induction of apoptosis in
human cancer cells. |
2009 |
|
|
|
|
|
|